IDH2 and oligodendroglioma: On the other hand, among IDH-mutant 1p/19q co-deleted oligodendrogliomas, a trend towards both longer survival and longer time to malignant degeneration was evident for A/G patients; however, it did not reach the 95% statistical significance level (p = 0.234 and p = 0.281, respectively).